Prevalence of dermatological manifestations of coronavirus disease 2019 (COVID‐19) is
estimated between 0.25% and 3% in children and adolescents. In this review article, we …

Various clinical manifestations of SARS-CoV-2 infections and adverse reactions to COVID-
19 vaccination have been described in children. The present narrative review aimed to …

COVID-19 can present with a range of skin manifestations, some of which specific of the
pediatric age. The aim of this systematic literature review was to determine the type …

Background Skin lesions are either caused by COVID-19 disease or they can be due to
other driving forces related to the COVID-19 pandemic. Aim Considering the fact that the …

There are ongoing worldwide registries, clinical and basic science studies to better
understand the burden of skin disease and pathophysiology of rashes seen in patients …

Rare and common manifestations of COVID‐19 in children - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

: Coronavirus disease 2019 (COVID-19) in previously healthy children is more likely to be
mild. However, COVID-19-related cutaneous manifestations in children can be categorized …

Background: Italy was the first country in Europe to report a SARS-CoV-2 case. Since then,
the country has suffered a large number of COVID-19 infections both in adults and children …

Chilblain-like lesions (CLL) coinciding with Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection have been described in the literature. Available …

La presentación clínica, curso de la enfermedad y resultado de la infección por SARS-CoV-
2 en pediatría difieren de los observados en adultos. En una revisión de Hoang et al. se …